ONWARD Medical Joins Stifel European Healthcare Summit to Discuss SCI Breakthroughs

EINDHOVEN, the Netherlands, June 26, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a pioneering medical technology company in the field of spinal cord stimulation, announced its participation in the esteemed Stifel European Healthcare Summit. The company is known for its revolutionary approach to developing therapies aimed at restoring movement, function, and independence for individuals affected by spinal cord injuries (SCI). ONWARD Medical's commitment to enhancing patient lives through innovation places it at the forefront of medical advancements in neuromodulation.

Advancing SCI Therapies at the Stifel Summit

At the Stifel European Healthcare Summit, ONWARD Medical N.V. showcased its latest research and development achievements, providing insights into its novel stimulation therapies that promise to transform treatment paradigms for SCI patients. The summit serves as a vital platform for healthcare companies and investors to discuss current trends and future growth opportunities in the sector. ONWARD Medical's participation underscores its role as an influential healthcare innovator and its dedication to creating value for both patients and shareholders.

Investor Outlook on ONWARD Medical's Prospects

Investors and stakeholders in the healthcare sector have closely monitored ONWARD Medical's trajectory due to its focus on addressing a critical area of unmet medical need. Through the development of advanced spinal cord stimulation techniques, the company has demonstrated potential for significant clinical and commercial impact. The interest in ONWARD Medical's work, especially in the context of the Stifel Summit, signals to the market that the company is not only a leader in SCI rehabilitation technology but also a promising investment opportunity.

ONWARD, Medical, Stifel